Changes in antigenic properties of human C3 upon activation and conversion by trypsin.
D000818:Animals; D000918:Antibody Specificity; D000941:Antigens; D003165:Complement System Proteins / Q000378:metabolism*; D004912:Erythrocytes / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D006736:Horses / Q000276:immunology; D006801:Humans; D007104:Immune Adherence Reaction; D007106:Immune Sera; D005779:Immunodiffusion; D007074:Immunoglobulin G; D007457:Iodine Radioisotopes; D010323:Passive Cutaneous Anaphylaxis; D011134:Polysaccharides; D011817:Rabbits / Q000276:immunology; D013997:Time Factors; D014357:Trypsin / Q000494:pharmacology*; D014361:Trypsin Inhibitors
D000941:Antigens; D007106:Immune Sera; D007074:Immunoglobulin G; D007457:Iodine Radioisotopes; D011134:Polysaccharides; D014361:Trypsin Inhibitors; D003165:Complement System Proteins; D014357:Trypsin